Our products

More than 2,500 topics covering disorders encountered in clinical practice, integrated into a single product for your computer or mobile.


Books

Printed volumes of common collections of topics, aggregated by clinical area. (Some book formats no longer available.)


Independent, reliable, respected

Therapeutic Guidelines is a leading source of independent, evidence-based, practical treatment advice to assist practitioners with decision making at the point-of-care.

Therapeutic Guidelines are regularly updated, based on the latest international literature, interpreted by Australia’s most respected experts, with input from an extensive network of general practitioners, pharmacists and other users.

December 2024 update

A major content update has been released:

Independence is an essential feature of Therapeutic Guidelines. Funded only by subscribers, meaning no grants, advertising, shareholders or sponsors. To protect and maintain independence, a strict conflict of interest policy is in place.

Therapeutic Guidelines is an independent not-for-profit organisation. Its aim is to promote the quality use of medicines, which it does this through the development, publication and sale of Therapeutic Guidelines.

Latest newsTwitterLinkedin

New release: Australian Prescriber December issue

The issue spotlights the timely topic of therapeutic use of vapes for smoking cessation and nicotine dependence and more.


Therapeutic Guidelines: new mobile app and content update 2024!

Therapeutic Guidelines has launched a new technology platform and mobile app to support more frequent content updates and modernise authentication processes. Our customers can download the new app from the Apple or Google Play Store. Major content updates to Palliative Care and Rheumatology are now available. Also, users can access a significant update to Toxicology and Toxicology, plus more than 100 additional updates across other guidelines.


New release: Australian Prescriber October issue

The new issue addresses 2 challenges in clinical practice: medicine shortages and inhaler devices for people with asthma or chronic obstructive pulmonary disease (COPD) and more.